Literature DB >> 30031006

Probing the Architecture, Dynamics, and Inhibition of the PI4KIIIα/TTC7/FAM126 Complex.

Gillian L Dornan1, Udit Dalwadi2, David J Hamelin1, Reece M Hoffmann1, Calvin K Yip2, John E Burke3.   

Abstract

Phosphatidylinositol 4-kinase IIIα (PI4KIIIα) is the lipid kinase primarily responsible for generating the lipid phosphatidylinositol 4-phosphate (PI4P) at the plasma membrane, which acts as the substrate for generation of the signaling lipids PIP2 and PIP3. PI4KIIIα forms a large heterotrimeric complex with two regulatory partners, TTC7 and FAM126. We describe using an integrated electron microscopy and hydrogen-deuterium exchange mass spectrometry (HDX-MS) approach to probe the architecture and dynamics of the complex of PI4KIIIα/TTC7/FAM126. HDX-MS reveals that the majority of the PI4KIIIα sequence was protected from exchange in short deuterium pulse experiments, suggesting presence of secondary structure, even in putative unstructured regions. Negative stain electron microscopy reveals the shape and architecture of the full-length complex, revealing an overall dimer of PI4KIIIα/TTC7/FAM126 trimers. HDX-MS reveals conformational changes in the TTC7/FAM126 complex upon binding PI4KIIIα, including both at the direct TTC7-PI4KIIIα interface and at the putative membrane binding surface. Finally, HDX-MS experiments of PI4KIIIα bound to the highly potent and selective inhibitor GSK-A1 compared to that bound to the non-specific inhibitor PIK93 revealed substantial conformational changes throughout an extended region of the kinase domain. Many of these changes were distant from the putative inhibitor binding site, showing a large degree of allosteric conformational changes that occur upon inhibitor binding. Overall, our results reveal novel insight into the regulation of PI4KIIIα by its regulatory proteins TTC7/FAM126, as well as additional dynamic information on how selective inhibition of PI4KIIIα is achieved.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FAM126; HDX-MS; PI4KA; TTC7; phosphatidylinositol 4-kinase

Mesh:

Substances:

Year:  2018        PMID: 30031006     DOI: 10.1016/j.jmb.2018.07.020

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme.

Authors:  Prajna Shanbhogue; Reece M Hoffmann; Michael V Airola; Rohan Maini; David J Hamelin; Miguel Garcia-Diaz; John E Burke; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2019-03-19       Impact factor: 5.157

Review 2.  Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.

Authors:  Ellie I James; Taylor A Murphree; Clint Vorauer; John R Engen; Miklos Guttman
Journal:  Chem Rev       Date:  2021-09-07       Impact factor: 72.087

3.  Pediatric Gastrointestinal Histopathology in Patients With Tetratricopeptide Repeat Domain 7A (TTC7A) Germline Mutations: A Rare Condition Leading to Multiple Intestinal Atresias, Severe Combined Immunodeficiency, and Congenital Enteropathy.

Authors:  Katelyn Dannheim; Jodie Ouahed; Michael Field; Scott Snapper; Bram P Raphael; Sarah C Glover; Phyllis R Bishop; Natalie Bhesania; Daniel Kamin; Jay Thiagarajah; Jeffrey D Goldsmith
Journal:  Am J Surg Pathol       Date:  2022-01-05       Impact factor: 6.298

4.  Biallelic PI4KA variants cause neurological, intestinal and immunological disease.

Authors:  Claire G Salter; Yiying Cai; Bernice Lo; Guy Helman; Henry Taylor; Amber McCartney; Joseph S Leslie; Andrea Accogli; Federico Zara; Monica Traverso; James Fasham; Joshua A Lees; Matteo P Ferla; Barry A Chioza; Olivia Wenger; Ethan Scott; Harold E Cross; Joanna Crawford; Ilka Warshawsky; Matthew Keisling; Dimitris Agamanolis; Catherine Ward Melver; Helen Cox; Mamoun Elawad; Tamas Marton; Matthew N Wakeling; Dirk Holzinger; Stephan Tippelt; Martin Munteanu; Deyana Valcheva; Christin Deal; Sara Van Meerbeke; Catherine Walsh Vockley; Manish J Butte; Utkucan Acar; Marjo S van der Knaap; G Christoph Korenke; Urania Kotzaeridou; Tamas Balla; Cas Simons; Holm H Uhlig; Andrew H Crosby; Pietro De Camilli; Nicole I Wolf; Emma L Baple
Journal:  Brain       Date:  2021-12-31       Impact factor: 15.255

Review 5.  Membrane Lipids in Epithelial Polarity: Sorting out the PIPs.

Authors:  Katlynn Bugda Gwilt; Jay R Thiagarajah
Journal:  Front Cell Dev Biol       Date:  2022-05-31

6.  A palmitoylation code controls PI4KIIIα complex formation and PI(4,5)P2 homeostasis at the plasma membrane.

Authors:  Alex G Batrouni; Nirmalya Bag; Henry T Phan; Barbara A Baird; Jeremy M Baskin
Journal:  J Cell Sci       Date:  2021-10-22       Impact factor: 5.235

Review 7.  The chemistry and biology of phosphatidylinositol 4-phosphate at the plasma membrane.

Authors:  Alex G Batrouni; Jeremy M Baskin
Journal:  Bioorg Med Chem       Date:  2021-05-01       Impact factor: 3.461

8.  A nanodomain-anchored scaffolding complex is required for the function and localization of phosphatidylinositol 4-kinase alpha in plants.

Authors:  Lise C Noack; Vincent Bayle; Laia Armengot; Frédérique Rozier; Adiilah Mamode-Cassim; Floris D Stevens; Marie-Cécile Caillaud; Teun Munnik; Sébastien Mongrand; Roman Pleskot; Yvon Jaillais
Journal:  Plant Cell       Date:  2022-01-20       Impact factor: 12.085

9.  Palmitoylation targets the calcineurin phosphatase to the phosphatidylinositol 4-kinase complex at the plasma membrane.

Authors:  Idil Ulengin-Talkish; Matthew A H Parson; Meredith L Jenkins; Jagoree Roy; Alexis Z L Shih; Nicole St-Denis; Gergo Gulyas; Tamas Balla; Anne-Claude Gingras; Péter Várnai; Elizabeth Conibear; John E Burke; Martha S Cyert
Journal:  Nat Commun       Date:  2021-10-18       Impact factor: 14.919

10.  Probing the subcellular distribution of phosphatidylinositol reveals a surprising lack at the plasma membrane.

Authors:  James P Zewe; April M Miller; Sahana Sangappa; Rachel C Wills; Brady D Goulden; Gerald R V Hammond
Journal:  J Cell Biol       Date:  2020-03-02       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.